Skip to content
SentinelMarket desk
Switch to dark mode

오가노이드사이언스

476040KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

6,200KRWMarket close of 10/21 (Wed)

Down -1.59%-100KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)5,970KRWDown -3.71%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
6,360
High
6,550
Low
6,200
Day range
Day range low 6,200 high 6,550, open 6,360, close 6,200, previous close 6,300
Volume
1×10K shares
64.81 million KRW 0.39× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 5,910 to 44,600 won, 1% up from the low

1% of the way up from the lowest close in 1 year (252 sessions) · -86.1% from the high

Usual range

Nothing unusual in the 3 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsnot verifiedThe last four quarters are incomplete, so not verified
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move-1.59%usual range
  • Trading value0.4×usual range
  • Data date10/21 (Wed)Market close
See the full check report

Quarterly results · Q2 2026

Source: DART financials (Q4 derived as annual − three quarters)
  • Revenue597.98 million KRWRevenue bars for the last 5 quarters; the dark bar is this quarter
    vs. year ago
    -1.1%
    vs. prior quarter
    +316.5%
  • Operating income-4.4B KRWOperating income bars for the last 5 quarters; the dark bar is this quarter
    vs. year ago
    Still a loss
    vs. prior quarter
    Still a loss
  • Operating margin-728.2%Operating margin bars for the last 5 quarters; the dark bar is this quarter
    vs. year ago
    +48.8 pp
    vs. prior quarter
    +2,227.0 pp

Quarterly operating income trend

As of the latest official close · 2026-10-21Valuation filing date · 2026-08-14
2025Q2 -4.7B KRW2026Q2 -4.4B KRW

Same sector · 바이오 R&D

Up +3.03%

· 33 of 64 stocks up, preferred shares excluded · trading value 215.2B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -5.5%Up +3.90%60.7B KRW
올릭스Close over the last 20 sessions -6.4%Up +9.53%26.1B KRW
디앤디파마텍Close over the last 20 sessions -6.0%Up +6.65%22.0B KRW
리가켐바이오Close over the last 20 sessions -14.3%Up +2.00%12.9B KRW
프로티나Close over the last 20 sessions +35.7%Up +7.23%11.0B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 25 days
  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.